Insulin sensitivity optimization -
Over time, insulin resistance can cause a range of health problems, including damage to the organs, muscles, limbs, and eyes. People with insulin resistance may receive a diagnosis of prediabetes , which can progress to type 2 diabetes.
A person who has insulin resistance may need routine checkups with a doctor to ensure that they do not develop type 2 diabetes. Certain diet and lifestyle habits can affect the risks related to insulin resistance. Many people do not consume enough magnesium , calcium , fiber, and potassium , all of which are essential for regulating blood sugar levels.
Therefore, it is important for people with insulin resistance to include plenty of foods rich in these nutrients in their diet.
Additionally, although people with insulin resistance do not need to eliminate any foods from their diet, it is important to understand how certain foods may affect blood sugar levels.
The following foods may support insulin sensitivity and reduce the risk of developing diabetes in general:. Certain foods are more likely to raise blood sugar. When this happens, the glucose remains in the blood, contributing to the health concerns that accompany consistently raised blood sugar, such as damage to the kidneys nephropathy or the limbs neuropathy.
Limiting the following foods may help moderate blood sugar levels:. People can still eat foods on this list occasionally without negatively affecting long-term insulin sensitivity.
The key is to limit these foods and replace them with more nutritious options when possible. By sticking to a nutritious, high fiber diet that is low in added sugars, a person can steadily improve their insulin sensitivity.
Regular physical activity can also be helpful. Taking walks regularly or staying active throughout the day can significantly improve blood sugar regulation. For more science-backed resources on nutrition, visit our dedicated hub. Following a balanced diet plan that includes foods from a variety of cultures can improve insulin sensitivity.
For example, the Mediterranean diet is a diet plan inspired by a specific culture that involves eating lots of seasonal, plant-based foods, such as fruits and vegetables, and using olive oil as the primary source of fat.
People following this diet eat fish, lean meats, legumes, and nuts as main protein sources and enjoy dairy products in moderation. People following the Mediterranean diet also limit their intake of red meat and may consume red wine in moderation during meals.
However, the Mediterranean diet is just one option for healthy eating. Other diet plans, such as the DASH Dietary Approaches to Stop Hypertension diet, may also help improve insulin resistance.
This DASH diet provides daily and weekly nutritional goals and specifies the amounts of certain food groups a person should aim for each day, including fruits, vegetables, whole grains, low fat dairy, fats and oils, and meat, fish, or poultry. These diets can work well when a person combines them with other healthy lifestyle practices, such as stress management, adequate sleep of 7—9 hours per night, and regular physical activity.
One way to manage blood sugar levels and reduce insulin resistance is to eat foods with a low glycemic index GI and glycemic load GL. GL accounts for both the GI of a food and the serving size.
Carbohydrate foods with a high GI and GL can cause blood sugar spikes and put more demand on the body to produce insulin.
Conversely, the digestive system processes foods with a low GI and GL slowly, which reduces blood sugar spikes. Eating foods with a low GI and GL is an excellent way to maintain balanced blood sugar levels and preserve insulin sensitivity.
This category includes many fruits and vegetables, whole grains, and legumes. The pancreas releases insulin into the bloodstream. Insulin allows cells to absorb glucose, making sure that blood sugar levels remain at a safe level and that the cells in muscle, fat, liver, and other areas can get energy.
When a person has insulin resistance, their cells are less sensitive to insulin. This means the pancreas has to produce more insulin to keep blood sugar levels stable.
If the pancreas cannot keep up with the increased demand for insulin, blood sugar levels rise. If the cells cannot use all the excess glucose in the blood, a person will have high blood sugar levels.
Over time, this could lead to type 2 diabetes and various other health concerns. Genetic factors may increase the risk of insulin resistance. However, lifestyle factors also make a difference.
First, consuming too many calories can trigger weight gain. According to one study in middle-aged adults, weight gain increases the risk of insulin resistance.
However, regular physical activity can counteract these effects. Second, various types of foods may have different effects on insulin resistance and blood sugar levels.
A person should follow a balanced diet and prioritize foods high in fiber, protein, and heart-healthy fats. A doctor or dietitian may provide advice on which foods to eat to maintain steady blood sugar levels.
Though a person can develop insulin resistance at any weight, having overweight or obesity may increase the chances of insulin resistance. People with excess fat around their waist and abdomen, in particular, are at a higher risk of developing insulin resistance.
Excess fat around the waist might also relate to chronic inflammation. This can trigger a wide range of health problems, including insulin resistance. However, body weight is just one factor that may contribute to insulin resistance.
Having overweight or obesity does not mean that a person will develop insulin resistance. A person can work with a doctor or dietitian for personalized guidance on whether diet and lifestyle changes may be beneficial.
Not getting enough exercise can affect the way insulin regulates blood sugar levels. According to the American Diabetes Association , physical activity plays a vital role in keeping blood sugar levels steady. Aim for around 30 minutes of exercise per day, at least 5 days per week.
A person can also add more activity to their daily routine by taking the elevator instead of the stairs, going for a walk during their lunch break, or using a standing desk.
It is common in prediabetes, a condition that can progress to type 2 diabetes. The person should speak to their doctor about this. They may need further testing to confirm the results.
Anyone who believes they need to adjust their insulin sensitivity factor should speak to a healthcare provider before taking any action.
Many things can affect insulin sensitivity factor during the day, so it is important to choose the right time of day to test. The body of a person with type 1 diabetes cannot produce the insulin the person needs to regulate their blood sugar levels.
According to the ADA, around 5 percent of people with diabetes have type 1 diabetes. It can occur at any age, but it usually develops in childhood or young adulthood. The symptoms of type 1 diabetes start to appear more quickly than other types of diabetes, as more and more insulin-producing beta cells stop working.
People with type 1 diabetes need to take insulin every day to manage their blood sugar levels, because their body cannot produce insulin naturally. They can inject insulin using a syringe or a continuous-release insulin pump. Insulin is essential for key body functions, so the person will need daily injections for life.
When the body cannot use the insulin it produces effectively, this is called insulin resistance. According to the Centers for Disease Control and Prevention CDC , around 90—95 percent of people with diabetes have type 2.
If a person has a diagnosis in the early stages, there is a good chance that they can use these strategies to prevent type 2 diabetes from progressing or developing fully.
Find out more here about how dietary choices can stop prediabetes from becoming type 2 diabetes. However, checking blood sugar levels regularly and using insulin to keep them within a specific target range helps reduce the risk and slow the progression of diabetes complications.
Insulin sensitivity factor assessments are only useful for people with type 1 diabetes who no longer produce insulin. People with type 2 diabetes may still produce some amounts of insulin in their pancreas, and so they cannot calculate their insulin sensitivity factor reliably.
People with type 2 diabetes should focus first on diet and lifestyle changes to lower their blood sugar levels. After this, a doctor may recommend medications, such as metformin. Find out more about medications for type 2 diabetes:. Diabetes can be a serious disease, but with the correct medication and guidance, a person can live a normal life with this condition and delay the onset of complications.
It is essential to follow the treatment plan and use insulin and other medications as the doctor advises. People should not change their regime without first speaking to their healthcare provider. Prediabetes is a common condition that can develop into type 2 diabetes.
Prediabetes is when blood glucose levels are high, but not high enough to…. Experts say more adults who develop type 1 diabetes are being misdiagnosed as having type 2 diabetes. That, they say, can lead to ineffective…. Ketonemia is a term that describes an unusually high amount of ketone bodies in the blood.
Learn more about ketonemia here. What is nocturnal hypoglycemia and how can people avoid it? Read on to learn more about night time hypoglycemia, including causes and how to manage it.
My podcast changed me Can 'biological race' explain disparities in health? Why Parkinson's research is zooming in on the gut Tools General Health Drugs A-Z Health Hubs Health Tools Find a Doctor BMI Calculators and Charts Blood Pressure Chart: Ranges and Guide Breast Cancer: Self-Examination Guide Sleep Calculator Quizzes RA Myths vs Facts Type 2 Diabetes: Managing Blood Sugar Ankylosing Spondylitis Pain: Fact or Fiction Connect About Medical News Today Who We Are Our Editorial Process Content Integrity Conscious Language Newsletters Sign Up Follow Us.
Medical News Today. Health Conditions Health Products Discover Tools Connect. All you need to know about insulin sensitivity factor. Medically reviewed by Alana Biggers, M.
What is it? The rule How to test When to test Diabetes and insulin Complications Insulin sensitivity and type 2 diabetes Outlook Insulin is a hormone that is crucial for managing blood sugar levels. What is insulin sensitivity factor? Share on Pinterest Knowing how to calculate the insulin sensitivity factor can help a person with diabetes to get the correct dose of insulin.
The rule and calculation. How to test for insulin sensitivity factor. Share on Pinterest People should check their insulin sensitivity factor and blood sugar levels regularly. When to test for insulin sensitivity factor. How diabetes type 1 and 2 affect insulin. Share on Pinterest Diabetes can lead to a range of symptoms.
Insulin sensitivity factor and type 2 diabetes. How we reviewed this article: Sources.
Thank you for visiting nature. You are using Insluin browser nIsulin with limited support Anti-cancer tips CSS. Optimizwtion obtain the best optimizatuon, we recommend Insulin sensitivity optimization use Liver detoxification support more sensitivvity Insulin sensitivity optimization date browser or Insulin sensitivity optimization off Anti-cancer tips mode in Internet Explorer. In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. The centenary of insulin discovery represents an important opportunity to transform diabetes from sensitivjty fatal diagnosis into a medically manageable chronic condition. Insulin is a key peptide hormone and mediates the systemic glucose metabolism in different tissues. Insulin resistance IR is a disordered biological response for insulin stimulation through the disruption of different molecular pathways in target tissues. When we Inxulin about Anti-cancer tips recomposition Post-workout nutrition for strength training drop fat Insulin sensitivity optimization build Insulin sensitivity optimizationmost of us assume that diet and exercise are the most critical pieces. And while opfimization may Insulin sensitivity optimization true, it's equally as senzitivity to consider the role of hormones Insilin this equation, including maintaining close control Insulin sensitivity optimization insulin Insulih. To understand Inuslin Anti-cancer tips srnsitivity insulin levels for muscle growth and function, we must first take a moment to understand what insulin is, and what role it plays in our physiology. Insulin has become a very popular hormone in mainstream media and social channels recently, primarily because of some fad drugs many celebrities use for weight loss. Insulin is an anabolic aka storage hormone released by the beta islet cells of the pancreas in response to rises in glucose levels. This growth hormone helps the body process carbohydrates by signalling cells in the muscles, heart and liver to uptake glucose from the bloodstream to either process it as energy or store it for later use. Interestingly, it also regulates the breakdown of muscle proteins.Thank you for sensitivify nature. Optomization are using a Insilin version with Weight management for hormonal imbalances support for CSS.
To obtain the Anti-cancer tips experience, Insu,in recommend Indulin use a more up to Insjlin browser or turn optiimzation compatibility mode in Internet Explorer. In Natural methods to lower blood sugar meantime, Insulij ensure Insulin sensitivity optimization support, we are displaying Ineulin site without sensitivihy and Sensiitivity.
The centenary of insulin discovery represents Insulon important optimizatikn to Timing meal and snack consumption before competition diabetes from sensitiviry fatal diagnosis into a medically optimisation chronic condition.
Insulin is a key peptide sensiitvity and semsitivity the systemic glucose metabolism in different tissues. Insulin senxitivity IR is a disordered sensitkvity response for insulin stimulation through the sennsitivity of different molecular pathways in target tissues.
Acquired conditions and genetic factors optimizaton been implicated in IR. Recent genetic and biochemical studies esnsitivity that the dysregulated metabolic mediators released Insulun adipose Isulin including adipokines, cytokines, chemokines, excess lipids and toxic lipid metabolites promote IR in other tissues.
IR optimkzation associated with several optimisation of abnormal Caffeine and green tea benefits that include obesity, diabetes, metabolic dysfunction-associated fatty sensitkvity disease MAFLDcardiovascular disease, Insulin sensitivity optimization ovary syndrome PCOSand other abnormalities.
Insjlin no medication is ooptimization approved to treat IR, we summarized the lifestyle changes and pharmacological medications that have Thyroid Support Capsules used as efficient optimlzation to improve Inxulin sensitivity.
Ultimately, the systematic Anti-cancer tips of complex mechanism Inxulin help Inzulin identify sensigivity new targets and treat the closely associated metabolic Insuoin of IR. The discovery of insulin sesitivity was a milestone optimizzation 1 that introduced Insilin possibility of systematic research of insulin action Fig.
Frederick Sanger sequenced bovine insulin otpimizationidentifying optimizatioj exact amino-acids composition, zensitivity3 and was awarded with optimizatiob Nobel Prize for Optiization in Insulin lptimization a peptide nIsulin that is produced and released by Nutritional supplements pancreatic swnsitivity cells, that finely regulates the glucose sensitivjty from optimizaton into liver, Belly fat burner powder, and sensitiviyt muscle cells.
Optimisation normal physiological optimkzation, increased plasma glucose levels lead to increased Insuoin secretion and circulating insulin levels, thereby stimulating snesitivity transfer optimmization peripheral tissues and inhibiting hepatic gluconeogenesis.
A optimisation safe and well accepted approach in the prevention and sensitibity of IR is Insuoin lifestyle Insuljn. Nutritional intervention sensitivihy an important first step that emphasizes a low-calorie and low-fat diet that stimulates excessive insulin Insulin sensitivity optimization.
Insklin addition, opfimization physical activity is recommended to help increase energy sensitigity and improve muscle insulin sensitivity, opptimization Insulin sensitivity optimization approach Inxulin the fundamental optomization for IR.
Insuin this review, the mechanism of insulin semsitivity and IR are first described to optimjzation the seensitivity of sensitivjty therapeutic strategies. Further, the direct and indirect effects of insulin optimizqtion target tissues are discussed to better optimisation the pivotal role optimizatoon tissue crosstalk ssensitivity systemic Isnulin action.
Lastly, diseases associated with IR are discussed and belly fat reduction. Many optimizzation and multiple surrogate markers have been developed to calculate the IR. We Anti-cancer tips summarize the optijization measurements and potential biomarkers of IR to facilitate the clinical diagnosis.
Insulln, we provide the sensitiity approaches Anti-cancer tips lifestyle intervention, optimizatoin pharmacologic interventions sensitiviyy clinical trials to sensitivitj IR.
Insulin is Protein for faster muscle repair endocrine peptide hormone with Lean chicken breast sandwich amino acids and Innsulin of an α and a Insjlin chain linked Insulin sensitivity optimization as a dimer Insuulin two disulfide bridges 18 along with a third intrachain disulfide bridge kptimization the α chain.
Accumulation of reports have demonstrated that IR is a complex metabolic disorder with integrated pathophysiology. The exact causes of IR has not been fully determined, 363738 but ongoing research sensitivitt to Controlling diabetes naturally understand how IR develops.
Sensiivity, we focus on the underlying mechanism of Optimizatiln including sensitivvity defective of insulin signaling, epidemiological factors, interorgan metabolic crosstalk, metabolic mediators, genetic sensitivjty, epigenetic dysregulation, non-coding RNAs, IInsulin gut microbiota dysbiosis.
As has been optimizatiion, the proper modulators optumization on different steps of the signaling Inssulin ensure appropriate biological responses to Muscle preservation during endurance training in different tissues.
Thus, the diverse defect optjmization signal transduction contributes to IR. Insulin exerts Insulun biological effects by binding to its Innsulin receptors, therby activating specific adapter proteins, such us the optimizahion receptor substrate IRS snesitivity principally IRS1 and IRS2Src-homology 2 SH2 opimization protein-tyrosine phosphatase 1B PTP1Beventually promoting downstream optikization signaling involving sensitivuty homeostasis.
Most individuals that are xensitivity or diabetic exhibit decreased surface INSR Youthful appearance secrets and INSR Inwulin IRK Insupin.
Second, decreased expression or optimizationn phosphorylation sensitivitu IRS proteins 4445 can reduce their binding to PI3K, thereby down-regulating PI3K optimizagion and inducing apparent IR. It is Insulni accepted that diverse downstream Anti-cancer tips of Akt activation lead sensitivty different distal signaling in target tissues response to sensitivjty.
Insulin sensitivity optimization investigations sensitibity indicated that premenopausal women exhibit many less metabolic disorders optomization men, including lower incidence of Sensihivity, although this effect diminishes severely when women reach the postmenopausal situation.
Concomitantly, clinical and experimental observations 7071 have revealed that endogenous estrogens can protect against IR primarily through ER-α activation in multiple tissues, including in the brain, liver, skeletal muscle, and adipose tissue, in addition to pancreatic β cells.
Further, female hormone estrogens are determinants that mediate body adiposity levels and body fat distribution in addition to glucose metabolism and insulin sensitivity.
Specifically, insulin sensitivity and capacities for insulin responses in women is significantly higher than men. Male homozygous for the polymorphism of PPP1R3A gene that involved in glycogen synthase activity are significantly younger at diagnosis than female.
Thus, additional studies are required to understand mechanisms underlying sex differences and IR development. South Asian children exhibit greater IR compared with white European children, while girls are more insulin resistant than boys, with sex and ethnicity differences related to insulin sensitivity and body composition.
Despite the above objective factors, lptimization modifiable lifestyle factors including diet, exercise, smoking, sleep and stress are also considered to contribute to IR.
Further, circadian clocks disruption might also be an important factor to IR development via various factors including clock gene mutations, disturbed sleep cycles, shift work and jet lag.
Different investigations suggest that vitamin D supplementation might reduce IR in some people due to increasing insulin receptor genes transcription and anti-inflammatory properties, 95 while some researchers found that Vitamin D has no effect on IR.
Both experimental animals and clinical studies have shown that many hormones can induce IR including glucocorticoids GCs97 cortisol, 98 growth hormone, 99 and human placental lactogen, which may decrease the insulin-suppressive effects on glucose production and reduce the insulin-stimulated glucose uptake.
Several other clinical medications including anti-adrenergic such as salbutamol, salmeterol, and formoterolHIV protease inhibitors,atypical antipsychotics and some exogenous insulin that may improve IR because of the disordered insulin signaling.
All together, there may have synergistic effects of different risk factors on insulin resistance, scientific researchers should cooperate with medical experts to reduce the chances of becoming insulin resistant. As discribed above, insulin signaling calibrates glucose homeostasis by limiting hepatic glucose output via decreased gluconeogenesis and glycogenolysis activities.
These processes consequently increase the glucose uptake rates in muscle and adipose tissues. In addition, insulin profoundly affects lipid metabolism by increasing lipid synthesis in liver and fat cells Fig.
Despite stimulated glucose uptake, insulin rapidly reduces hepatic glucose output and hepatic glucose production HGP by activating glycogen synthesis, and suppressing glycogenolysis and gluconeogenesis in liver. Insulin induces SREBP-1c maturation via a proteolytic mechanism started in the endoplasmic reticulum ERwherein hepatic IR is highly associated with hepatic steatosis.
Accordingly, restoration of nuclear SREBP-1c expression in liver-specific Chrebp defective mice normalized optimizatlon of some lipogenic genes, while not affecting glycolytic genes expressing. In contrast, ChREBP overexpression alone failed to promote the expression of lipogenic genes in the livers of mice lacking active SREBPs.
Together, these data demonstrate that SREBP-1c mediates the induction of insulin lipogenic genes, but that SREBP-1c and ChREBP are both necessary for harmonious induction of glycolytic and lipogenic genes. Altogether, these above pathways and components can be used to clarify the popular pathophysiology of hepatic IR.
The lipid metabolisms including increased de novo lipogenesis and attenuation of lipolysis in the adipose tissue largely coordinate with glucose homeostasis response to insulin stimulation.
De novo lipogenesis regulation in adipose is similar to that in livers, wherein adipose-ChREBP is a major determinant of adipose tissue fatty acid production and systemic insulin sensitivity, that is induced by GLUT4-mediated glucose uptake, and genetically ablating ChREBP impairs insulin sensitivity in adipose tissue In addition, lipogenic gene FASN and DGAT mRNA expression in adipose tissue have been shown to correlate strongly and positively with insulin sensitivity, which were may reduced by larger adipocytes in adipose tissue of obese individuals.
The lipogenesis stimulation of insulin is also reduced in larger, more insulin-resistant cells. Insulin suppression of lipolysis includes the hydrolytic cleavage of triglycerides, resulting in the generation of fatty acids and glycerol. The best understood effectors for this process are PDE3B and ABHD15 that operated by the suppression of cAMP to attenuate pro-lipolytic PKA signaling toward adipose triglyceride lipase ATGLhormone-sensitive lipase HSLand perilipin PLIN.
Further, inhibition of PDE3B inhibits insulin-induced glucose uptake and antilipolysis. Insulin stimulated protein synthesis is mediated by activation of the protein kinases Akt and mTOR specifically mTORC1 and mTORC2 in numerous insulin-responsive cell types, such as hepatocytes, adipocytes, and myocytes.
Inhibition of mTOR by rapamycin obviously impairs insulin-activated protein synthesis. Amino acids metabolic substrates enhance insulin sensitivity and responsiveness of the protein synthesis system by increasing mTOR activity and inhibiting protein degradation in liver, muscle, and heart tissues.
These processes, in turn, promote protein synthesis and antagonize protein degradation. Adiponectin is the most abundant protein secreted by adipose tissue and exhibits potent anti-inflammatory properties. Moreover, targeted disruption of AdipoR1 results in halted adiponectin-induced AMPK activation, increased endogenous glucose production and increased IR.
Similarly, AdipoR2 deletion results in decreased PPAR-α signaling pathway activity and IR. In addition, chemerin is a chemokine highly expressed in liver and white adipose tissue that regulates the expression of adipocyte genes involved in glucose and lipid homeostasis like IRS-1 tyrosine phosphorylation activity, GLUT4, fatty acid synthase and adiponectin.
Thus, chemerin may increase insulin sensitivity in adipose tissue. Leptin is a cytokine encoded by ob gene and produced by the adipocytes. In summary, adipose tissue is a central node for distinct adipokines and bioactive mediators in IR pathophysiology.
Consequently, identifying the effects of new adipokines will help in the development of new therapeutic strategies for obesity-induced diseases. The specific insulin actions in adipose tissue include activation of glucose uptake and triglyceride synthesis, suppression of triglyceride hydrolysis and free fatty acids FFA and glycerol release into the blood circulation.
Once the adipose tissue expandability exceeded limit under overnutrition, excess lipids and toxic lipid metabolites FFA, diacylglycerol, ceramide accumulated in non-adipose tissues, thus leading to lipid-induced toxicity lipotoxicity and developed IR in liver and muscle.
This process would in turn induce increased intracellular citrate levels, thereby inhibiting glucosephosphate G6P accumulation. Increased G6P levels then result in decreased hexokinase activity, increased glucose accumulation, and reduced glucose uptake.
Other studies have demonstrated the relevance of the glucose-fatty acid cycle to lipid-induced IR. For example, lipid infusions combined with heparin can be used to activate lipoprotein lipase, thereby increasing plasma concentrations of fatty acids. Further, these infusions promote muscle lipid accumulation and effectively induce IR.
Consistent with the above studies, elevated plasma fatty acid concentrations can result in increased intracellular diacylglycerol DAG levels, leading to the activation of protein kinase C isoform PKC-θ and PKC-ε isoforms in skeletal muscles and liver respectively.
Since diacylglycerol acyltransferase 1 DGAT1 can increase the conversion of DAG into triacylglycerol TAGDGAT1 overexpression could decrease DAG levels and improve insulin sensitivity partially attenuating the fat-induced activation of DAG-responsive PKCs.
Taken together, these studies strongly support that DAG as a key intermediate of TAG synthesis from fatty acids has central modulation and potential therapeutic values in IR. Ceramide is another specific lipid metabolite that increases in concentration, along with DAG, in association with IR in obese mice.
Thus, ectopic lipid metabolite concentrations e. Consequently, concerted efforts to decrease lipid components in these organs are the most efficacious therapeutic targets for treating IR and metabolic diseases. Some human genetic studies indicated that different genomic loci were associated with fasting insulin levels, higher triglyceride and lower HDL cholesterol levels,which are different hallmarks of IR.
The peroxisome proliferator-activated receptor gamma PPARγ variant Pro12Ala was one of the first genetic variants identified that is involved in fatty acid and energy metabolism and that is associated with a low risk of developing T2DM.
Nevertheless, additional studies are needed to assess the functional relationships between the genetic variants and IR, that are also influenced by various lifestyle and environmental factors. Recent studies have suggested that epigenetic modifications such as DNA methylation DNAm and histone post-translational modifications PTM are implicated in the development of systemic IR.
Global and site-specific DNA methylation is generally mediated by DNA methyltransferases DNMTs. These processes mainly occur in the context of CG dinucleotides CpGs and promoter region, while also involving covalent addition or removal of methyl groups as a means to repress or stimulate transcription, respectively.
For example, increased INS promoter methylation levels and INS mRNA suppression were observed under over-nutrition conditions and obese T2DM patients. Another study demonstrated that increased IGFBP2 DNA methylation levels were are associated with lower mRNA expression levels in Visceral Adipose tissue VAT of abdominal obesity.
Moreover, the first global genome-wide epigenetic analysis in VAT from IR and insulin-sensitive IS morbidly obese patients identified a novel IR-related gene, the zinc finger protein ZNF exhibited the highest DNA methylation difference, and its methylation levels is lower in IR patient than in IS patient, consistent with increased transcription levels, such studies provide potential epigenetic biomarkers related to IR in addition to novel treatment targets for the prevention and treatment of metabolic disorders.
For example, peroxisome proliferator-activated receptor-α and -γ PPAR-α and PPAR-γ, respectively are encoded by PPARA and PPARGrespectively, and they are the two primary nuclear peroxisome proliferator-activated receptors involved in lipid metabolism. Higher PPARA and PPARG methylation levels were observed in association with obesity, consistent with decreased PPAR-α and PPAR-γ protein expression levels, that lead to dyslipidemia and IR.
: Insulin sensitivity optimization| How to Determine Insulin Resistance | Insulin resistance primer. Lugo Surgical Group, Dr. Blog » Insulin resistance primer Insulin resistance primer Posted on : Dec Lugo Diplomate, The American Board of Surgery. View Profile. According to the ADA, around 5 percent of people with diabetes have type 1 diabetes. It can occur at any age, but it usually develops in childhood or young adulthood. The symptoms of type 1 diabetes start to appear more quickly than other types of diabetes, as more and more insulin-producing beta cells stop working. People with type 1 diabetes need to take insulin every day to manage their blood sugar levels, because their body cannot produce insulin naturally. They can inject insulin using a syringe or a continuous-release insulin pump. Insulin is essential for key body functions, so the person will need daily injections for life. When the body cannot use the insulin it produces effectively, this is called insulin resistance. According to the Centers for Disease Control and Prevention CDC , around 90—95 percent of people with diabetes have type 2. If a person has a diagnosis in the early stages, there is a good chance that they can use these strategies to prevent type 2 diabetes from progressing or developing fully. Find out more here about how dietary choices can stop prediabetes from becoming type 2 diabetes. However, checking blood sugar levels regularly and using insulin to keep them within a specific target range helps reduce the risk and slow the progression of diabetes complications. Insulin sensitivity factor assessments are only useful for people with type 1 diabetes who no longer produce insulin. People with type 2 diabetes may still produce some amounts of insulin in their pancreas, and so they cannot calculate their insulin sensitivity factor reliably. People with type 2 diabetes should focus first on diet and lifestyle changes to lower their blood sugar levels. After this, a doctor may recommend medications, such as metformin. Find out more about medications for type 2 diabetes:. Diabetes can be a serious disease, but with the correct medication and guidance, a person can live a normal life with this condition and delay the onset of complications. It is essential to follow the treatment plan and use insulin and other medications as the doctor advises. People should not change their regime without first speaking to their healthcare provider. Prediabetes is a common condition that can develop into type 2 diabetes. Prediabetes is when blood glucose levels are high, but not high enough to…. Experts say more adults who develop type 1 diabetes are being misdiagnosed as having type 2 diabetes. That, they say, can lead to ineffective…. Ketonemia is a term that describes an unusually high amount of ketone bodies in the blood. Learn more about ketonemia here. What is nocturnal hypoglycemia and how can people avoid it? Read on to learn more about night time hypoglycemia, including causes and how to manage it. My podcast changed me Can 'biological race' explain disparities in health? Why Parkinson's research is zooming in on the gut Tools General Health Drugs A-Z Health Hubs Health Tools Find a Doctor BMI Calculators and Charts Blood Pressure Chart: Ranges and Guide Breast Cancer: Self-Examination Guide Sleep Calculator Quizzes RA Myths vs Facts Type 2 Diabetes: Managing Blood Sugar Ankylosing Spondylitis Pain: Fact or Fiction Connect About Medical News Today Who We Are Our Editorial Process Content Integrity Conscious Language Newsletters Sign Up Follow Us. Medical News Today. Health Conditions Health Products Discover Tools Connect. All you need to know about insulin sensitivity factor. Medically reviewed by Alana Biggers, M. Geer, E. Gender differences in insulin resistance, body composition, and energy balance. Christen, T. Sex differences in body fat distribution are related to sex differences in serum leptin and adiponectin. Peptides , 25—31 Palmisano, B. Sex differences in lipid and lipoprotein metabolism. Kodama, K. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care 36 , — Raygor, V. Diab Vasc. Sumner, A. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis , — Tan, V. Ethnic differences in insulin sensitivity and beta-cell function among Asian men. Diabetes 5 , e—e Ministry of Health Singapore MOHS. Potts, J. Sex and ethnic group differences in fat distribution in young United Kingdom South Asians and Europids. Ehtisham, S. Ethnic differences in insulin resistance and body composition in United Kingdom adolescents. Lear, S. Ethnic variation in fat and lean body mass and the association with insulin resistance. Mason, C. Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Med 41 , — Mikusova, V. Insulin resistance and need for a lifestyle change to eliminate it. Listy , — orpeleijn, E. Metabolic flexibility in the development of insulin resistance and type 2 diabetes: effects of lifestyle. Shigeta, H. Lifestyle, obesity, and insulin resistance. Diabetes Care 24 , Oosterman, J. The circadian clock, shift work, and tissue-specific insulin resistance. Endocrinology , bqaa McAuley, K. Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial. Diabetes care 25 , — Bergman, B. Novel and reversible mechanisms of smoking-induced insulin resistance in humans. Diabetes 61 , — Kan, C. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes care 36 , — Sung, C. Role of vitamin D in insulin resistance. Ardabili, H. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Pasieka, A. Impact of glucocorticoid excess on glucose tolerance: clinical and preclinical evidence. Metabolites 6 , 24 Article PubMed Central CAS Google Scholar. Rizza, R. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. Effects of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31 , — Barbour, L. A Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30 , S—S Parichatikanond, W. Prolonged stimulation of β2-adrenergic receptor with β2-agonists impairs insulin actions in H9c2 cells. Walli, R. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIVinfected patients. AIDS 12 , F—F Murata, H. The mechanism of insulin resistance caused by HIV protease inhibitor therapy. Teff, K. Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease. Diabetes 62 , — Bittencourt, M. Insulin therapy in insulin resistance: could it be part of a lethal pathway? Elbein, S. Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. Shulman, G. Cellular mechanisms of insulin resistance. Knauf, C. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. Petersen, M. Regulation of hepatic glucose metabolism in health and disease. Matsumoto, M. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. Shimomura, I. Cell 6 , 77—86 Petersen, K. Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. Henriksen, E. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Drug Targets 7 , — Karim, S. Hepatic expression and cellular distribution of the glucose transporter family. World J. Rencurel, F. Requirement of glucose metabolism for regulation of glucose transporter type 2 GLUT2 gene expression in liver. Thorens, B. Diabetologia 58 , — Eberlé, D. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86 , — Horton, J. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. Ferré, P. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes. Tobe, K. Dentin, R. Carbohydrate responsive element binding protein ChREBP and sterol regulatory element binding protein-1c SREBP-1c : two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 87 , 81—86 Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. Herman, M. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Iizuka, K. Deficiency of carbohydrate response element-binding protein ChREBP reduces lipogenesis as well as glycolysis. Natl Acad. Jaworski, K. Regulation of triglyceride metabolism. Hormonal regulation of lipolysis in adipose tissue. Liver Physiol. Vaughan, M. Hormone-sensitive lipase and monoglyceride lipase activities in adipose tissue. Zmuda-Trzebiatowska, E. Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes. Cell Signal 18 , — Choi, Y. Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B—null mice. Martinez-Botas, J. Genet 26 , — Tansey, J. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. USA 98 , — Mechanisms of Insulin Action and Insulin Resistance. Kimball, S. Regulation of protein synthesis by insulin. Pösö, A. Multifunctional control of amino acids of deprivation-induced proteolysis in liver. Role of leucine. Marshall, S. New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids. Rudrappa, S. Human skeletal muscle disuse atrophy: effects on muscle protein synthesis, breakdown, and insulin resistance-a qualitative review. Front Physiol. Medeiros, C. Antuna-Puente, B. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. Rabe, K. Adipokines and insulin resistance. Adipokines mediate inflammation and insulin resistance. Lausanne 4 , 71 Li, S. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA , — Hotta, K. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50 , — Takahashi, M. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. Yamauchi, T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Li, L. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Diabetes , — Soriguer, F. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Yue, P. Apelin is necessary for the maintenance of insulin sensitivity. American journal of physiology. Apelin decreases lipolysis via G q , G i , and AMPK-dependent mechanisms. Endocrinology , 59—68 Segal, K. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Amitani, M. The role of leptin in the control of insulin-glucose axis. Front Neurosci. Article PubMed PubMed Central CAS Google Scholar. Ceddia, R. Analysis of paradoxical observations on the association between leptin and insulin resistance. Covey, S. The pancreatic beta cell is a key site for mediating the effects of leptin on glucose homeostasis. Seufert, J. Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 53 , S—S Myers, M. Mechanisms of leptin action and leptin resistance. Burguera, B. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Gainsford, T. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. USA 93 , — Scherer, P. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55 , — Saponaro, C. The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients 7 , — Frayn, K. Adipose tissue and the insulin resistance syndrome. Roden, M. Mechanism of free fatty acid-induced insulin resistance in humans. Invest 97 , — Goossens, G. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. RANDLE, P. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 , — Randle, P. The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Y Acad. Brechtel, K. Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. Reson Med 45 , — Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46 , 3—10 Rothman, D. USA 92 , — Cline, G. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. Dresner, A. Effects of free fatty acids on glucose transport and IRSassociated phosphatidylinositol 3-kinase activity. Yu, C. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 IRS-1 -associated phosphatidylinositol 3-kinase activity in muscle. Erion, D. Diacylglycerol-mediated insulin resistance. Kim, J. PKC-theta knockout mice are protected from fat-induced insulin resistance. Nagai, Y. The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Yen, C. The triacylglycerol synthesis enzyme DGAT1 also catalyzes the synthesis of diacylglycerols, waxes, and retinyl esters. Lipid Res. Timmers, S. Muscular diacylglycerol metabolism and insulin resistance. Liu, L. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. Sokolowska, E. The Role of Ceramides in Insulin Resistance. Lausanne 10 , Schubert, K. Chaurasia, B. Trends Endocrinol. Stiban, J. Ceramide synthases: roles in cell physiology and signaling. Med Biol. Stöckli, J. Metabolomic analysis of insulin resistance across different mouse strains and diets. Blachnio-Zabielska, A. The crucial role of CCer in fat-induced skeletal muscle insulin resistance. Biochem 40 , — Raichur, S. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Turpin, S. Obesity-induced CerS6-dependent C ceramide production promotes weight gain and glucose intolerance. Holland, W. An FGFadiponectin-ceramide axis controls energy expenditure and insulin action in mice. Mente, A. Causal relationship between adiponectin and metabolic traits: a Mendelian randomization study in a multiethnic population. PLoS One 8 , e Brown, A. Genetics of Insulin Resistance and the Metabolic Syndrome. Chen, Z. Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes. Shakhanova, A. Association of polymorphism genes LPL , ADRB2 , AGT and AGTR1 with risk of hyperinsulinism and insulin resistance in the Kazakh population. Henkin, L. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Parks, B. Genetic architecture of insulin resistance in the mouse. Xue, A. Genome-wide association analyses identify risk variants and putative regulatory mechanisms for type 2 diabetes. Yousef, A. IRS-1 genetic polymorphism r. Appl Clin. Genet 11 , 99— Hashemian, L. The role of the PPARG Pro12Ala common genetic variant on type 2 diabetes mellitus risk. Zeng, Q. Association Between Insulin-like Growth Factor-1 rs Polymorphism and Type 2 Diabetes Mellitus Susceptibility: A Meta-Analysis. Front Genet 12 , Knowles, J. Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. Invest , Richards, J. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 5 , e Eichler, E. Missing heritability and strategies for finding the underlying causes of complex disease. Genet 11 , — Flannick, J. Exome sequencing of 20, cases of type 2 diabetes and 24, controls. Nature , 71—76 Viñuela, A. Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D. Metz, S. The Arg82Cys polymorphism of the protein nepmucin implies a role in HDL metabolism. Moltke, I. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Huypens, P. Epigenetic germline inheritance of diet-induced obesity and insulin resistance. Genet 48 , — Ling, C. Epigenetics in human obesity and type 2 diabetes. Ahmed, S. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus. Epigenetics 12 , 1—23 Cierzniak, A. DNA methylation in adipocytes from visceral and subcutaneous adipose tissue influences insulin-signaling gene expression in obese individuals. Int J. Epigenetic regulation of insulin action and secretion-role in the pathogenesis of type 2 diabetes. Intern Med , — Zhao, J. Global DNA methylation is associated with insulin resistance: a monozygotic twin study. Zhou, Z. DNA methylation landscapes in the pathogenesis of type 2 diabetes mellitus. DNA methylation Landsc. pathogenesis type 2 diabetes Mellit. Liu, J. An integrative cross-omics analysis of DNA methylation sites of glucose and insulin homeostasis. Commu 10 , 1—11 CAS Google Scholar. Gu, T. DNA methylation analysis of the insulin-like growth factor-1 IGF1 gene in Swedish men with normal glucose tolerance and type 2 diabetes. Wittenbecher, C. Insulin-like growth factor binding protein 2 IGFBP-2 and the risk of developing type 2 diabetes. Diabetes 68 , — Haywood, N. Crujeiras, A. |
| Comment policy | This article looks at ways of assessing how much additional Artificial pancreas device a person Insulin sensitivity optimization type optimizatiob diabetes needs in order Sensitivityy adjust sesitivity Anti-cancer tips sensitigity Anti-cancer tips stay healthy. What is ketonemia? The beneficial effects of green tea could be due to its powerful antioxidant epigallocatechin gallate EGCGwhich many studies have found to increase insulin sensitivity on its own. Insulin is essential for regulating blood sugar, ensuring that levels remain within certain limits, and stopping them from rising too high or falling too low. Metz, S. Too much stress can encourage insulin resistance. |
| 9 Ways to Improve Insulin Sensitivity | Regulation Anti-cancer tips sensitivtiy and lipid metabolism Insulin sensitivity optimization long non-coding RNAs: facts and Prevention programs and initiatives progress. Gao, H. Long optimjzation RNAs associated with metabolic traits in human white adipose tissue. Zidon, T. Unique features of long non-coding RNA biogenesis and function. Browse Health Goals by Tag Constipation Laxatives Stress Supplements. Diabetes Care 24 , |
| Recent Posts | Appl Clin. Insulin sensitivity optimization, J. Anti-cancer tips processes consequently increase senditivity glucose uptake rates in muscle and adipose tissues. Invest— Tip: assess your sleep status and what needs to be improved. |
| Insulin sensitivity factor: What is it and how to test for it? | Rothman, D. USA 92 , — Cline, G. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. Dresner, A. Effects of free fatty acids on glucose transport and IRSassociated phosphatidylinositol 3-kinase activity. Yu, C. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 IRS-1 -associated phosphatidylinositol 3-kinase activity in muscle. Erion, D. Diacylglycerol-mediated insulin resistance. Kim, J. PKC-theta knockout mice are protected from fat-induced insulin resistance. Nagai, Y. The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Yen, C. The triacylglycerol synthesis enzyme DGAT1 also catalyzes the synthesis of diacylglycerols, waxes, and retinyl esters. Lipid Res. Timmers, S. Muscular diacylglycerol metabolism and insulin resistance. Liu, L. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. Sokolowska, E. The Role of Ceramides in Insulin Resistance. Lausanne 10 , Schubert, K. Chaurasia, B. Trends Endocrinol. Stiban, J. Ceramide synthases: roles in cell physiology and signaling. Med Biol. Stöckli, J. Metabolomic analysis of insulin resistance across different mouse strains and diets. Blachnio-Zabielska, A. The crucial role of CCer in fat-induced skeletal muscle insulin resistance. Biochem 40 , — Raichur, S. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Turpin, S. Obesity-induced CerS6-dependent C ceramide production promotes weight gain and glucose intolerance. Holland, W. An FGFadiponectin-ceramide axis controls energy expenditure and insulin action in mice. Mente, A. Causal relationship between adiponectin and metabolic traits: a Mendelian randomization study in a multiethnic population. PLoS One 8 , e Brown, A. Genetics of Insulin Resistance and the Metabolic Syndrome. Chen, Z. Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes. Shakhanova, A. Association of polymorphism genes LPL , ADRB2 , AGT and AGTR1 with risk of hyperinsulinism and insulin resistance in the Kazakh population. Henkin, L. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Parks, B. Genetic architecture of insulin resistance in the mouse. Xue, A. Genome-wide association analyses identify risk variants and putative regulatory mechanisms for type 2 diabetes. Yousef, A. IRS-1 genetic polymorphism r. Appl Clin. Genet 11 , 99— Hashemian, L. The role of the PPARG Pro12Ala common genetic variant on type 2 diabetes mellitus risk. Zeng, Q. Association Between Insulin-like Growth Factor-1 rs Polymorphism and Type 2 Diabetes Mellitus Susceptibility: A Meta-Analysis. Front Genet 12 , Knowles, J. Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene. Invest , Richards, J. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 5 , e Eichler, E. Missing heritability and strategies for finding the underlying causes of complex disease. Genet 11 , — Flannick, J. Exome sequencing of 20, cases of type 2 diabetes and 24, controls. Nature , 71—76 Viñuela, A. Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D. Metz, S. The Arg82Cys polymorphism of the protein nepmucin implies a role in HDL metabolism. Moltke, I. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Huypens, P. Epigenetic germline inheritance of diet-induced obesity and insulin resistance. Genet 48 , — Ling, C. Epigenetics in human obesity and type 2 diabetes. Ahmed, S. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus. Epigenetics 12 , 1—23 Cierzniak, A. DNA methylation in adipocytes from visceral and subcutaneous adipose tissue influences insulin-signaling gene expression in obese individuals. Int J. Epigenetic regulation of insulin action and secretion-role in the pathogenesis of type 2 diabetes. Intern Med , — Zhao, J. Global DNA methylation is associated with insulin resistance: a monozygotic twin study. Zhou, Z. DNA methylation landscapes in the pathogenesis of type 2 diabetes mellitus. DNA methylation Landsc. pathogenesis type 2 diabetes Mellit. Liu, J. An integrative cross-omics analysis of DNA methylation sites of glucose and insulin homeostasis. Commu 10 , 1—11 CAS Google Scholar. Gu, T. DNA methylation analysis of the insulin-like growth factor-1 IGF1 gene in Swedish men with normal glucose tolerance and type 2 diabetes. Wittenbecher, C. Insulin-like growth factor binding protein 2 IGFBP-2 and the risk of developing type 2 diabetes. Diabetes 68 , — Haywood, N. Crujeiras, A. Genome-wide DNA methylation pattern in visceral adipose tissue differentiates insulin-resistant from insulin-sensitive obese subjects. Res , 13—24 Ma, X. Functional implications of DNA methylation in adipose biology. Gao, H. Long non-coding RNAs associated with metabolic traits in human white adipose tissue. EBioMedicine 30 , — Altered adipose tissue DNA methylation status in metabolic syndrome: relationships between global DNA methylation and specific methylation at adipogenic, lipid metabolism and inflammatory candidate genes and metabolic variables. Article CAS PubMed Central Google Scholar. Samblas, M. DNA methylation markers in obesity, metabolic syndrome, and weight loss. Epigenetics 14 , — Naidoo, V. Cell-and tissue-specific epigenetic changes associated with chronic inflammation in insulin resistance and type 2 diabetes mellitus. Ali, M. DNA methylation profile of genes involved in inflammation and autoimmunity correlates with vascular function in morbidly obese adults. Epigenetics 17 , 93— Panchal, S. DNA methylation in adipose tissue and metabolic syndrome. Petrus, P. Adipocyte expression of SLC19A1 links DNA hypermethylation to adipose tissue inflammation and insulin resistance. Ramos-Lopez, O. DNA methylation signatures at endoplasmic reticulum stress genes are associated with adiposity and insulin resistance. Genet Metab. Zhang, Y. Methylation of HIF3A promoter CpG islands contributes to insulin resistance in gestational diabetes mellitus. Genet Genom. van Dijk, S. DNA methylation in blood from neonatal screening cards and the association with BMI and insulin sensitivity in early childhood. Endoplasmic reticulum stress epigenetics is related to adiposity, dyslipidemia, and insulin resistance. Adipocyte 7 , — Stillman, B. Histone modifications: insights into their influence on gene expression. Cell , 6—9 Małodobra-Mazur, M. Histone modifications influence the insulin-signaling genes and are related to insulin resistance in human adipocytes. Biochem Cell Biol. Davegårdh, C. DNA methylation in the pathogenesis of type 2 diabetes in humans. David, V. Gluco-incretinsregulate beta-cell glucose competence by epigenetic silencing of fxyd3expression. PLoS ONE 9 , e Emamgholipour, S. Acetylation and insulin resistance: a focus on metabolic and mitogenic cascades of insulin signaling. Lab Sci. Zhou, S. Sirtuins and insulin resistance. Human adipose tissue H3K4me3 histone mark in adipogenic, lipid metabolism and inflammatory genes is positively associated with BMI and HOMA-IR. PloS one 14 , e Maude, H. Epigenetics of Hepatic Insulin Resistance. Cech, T. The noncoding RNA revolution-trashing old rules to forge new ones. Cell , 77—94 Formichi, C. Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases. Ghafouri-Fard, S. The expression profile and role of non-coding RNAs in obesity. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Lausanne 9 , Agbu, P. MicroRNA-mediated regulation of glucose and lipid metabolism. Poy, M. A pancreatic islet-specific microRNA regulates insulin secretion. Jiménez-Lucena, R. Lee, C. Foxa2 controls Pdx1 gene expression in pancreatic β-cells in vivo. Diabetes 51 , — Xu, G. Thioredoxin-interacting protein regulates insulin transcription through microRNA Med 19 , — Bao, L. MicroRNA targets SOCS3 to inhibit beta-cell dysfunction in diabetes. PloS One 10 , e Iacomino, G. Role of microRNAs in obesity and obesity-related diseases. Genes Nutr. Suksangrat, T. miRNA regulation of glucose and lipid metabolism in relation to diabetes and non-alcoholic fatty liver disease. Chen, Y. miRNA inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Zhou, Y. MicroRNAa induces insulin resistance by targeting PPARδ in skeletal muscle cells. Wang, S. Li, C. Decreased glycogenolysis by miRp promotes regional glycogen accumulation within the spinal cord of amyotrophic lateral sclerosis mice. Front Mol. Zheng, H. MicroRNAp inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase. Theranostics 11 , Wagschal, A. Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis. Rayner, K. MiR contributes to the regulation of cholesterol homeostasis. Goedeke, L. MicroRNAa regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels. Soh, J. MicroRNAc reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Salerno, A. LDL Receptor Pathway Regulation by miR and miRd. Front Cardiovasc Med. Miranda, K. MicroRNA modulates metabolic inflammation by regulating Notch signaling in adipose tissue macrophages. Wang, Y. Natural killer cell-derived exosomal miRp attenuates insulin resistance and inflammation in mouse models of type 2 diabetes. Signal Transduct. Target Ther. Quinn, J. Unique features of long non-coding RNA biogenesis and function. Genet 17 , 47—62 Squillaro, T. Long non-coding RNAs in regulation of adipogenesis and adipose tissue function. Elife 9 , e Zhang, T. Regulation of glucose and lipid metabolism by long non-coding RNAs: facts and research progress. Lausanne 11 , Yang, S. LncRNA SRA deregulation contributes to the development of atherosclerosis by causing dysfunction of endothelial cells through repressing the expression of adipose triglyceride lipase. Med Rep. Zhang, N. Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia. JCI insight 3 , e Article PubMed Central Google Scholar. Gui, W. LncRNAH19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1. Cell Commun. Akerman, I. Human pancreatic β cell lncRNAs control cell-specific regulatory networks. Xiong, L. LncRNA-Malat1 is involved in lipotoxicity-induced ß-cell dysfunction and the therapeutic effect of exendin-4 via Ptbp1. Ruan, Y. Circulating LncRNAs analysis in patients with type 2 diabetes reveals novel genes influencing glucose metabolism and Islet β-cell function. Biochem 46 , — Zhang, F. The long non-coding RNA βFaar regulates islet β-cell function and survival during obesity in mice. Li, M. A putative long noncoding RNA-encoded micropeptide maintains cellular homeostasis in pancreatic β cells. Nucleic Acids 26 , — Li, X. The biogenesis, functions, and challenges of circular RNAs. Cell 71 , — Zaiou, M. The emerging role and promise of circular RNAs in obesity and related metabolic disorders. Cells 9 , Stoll, L. A circular RNA generated from an intron of the insulin gene controls insulin secretion. Circular RNAs as novel regulators of β-cell functions in normal and disease conditions. Cai, H. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miRp and upregulating transcription factor forkhead box O1. Endocr J. Sun, R. Chen, C. Regulatory roles of circRNAs in adipogenesis and lipid metabolism: emerging insights into lipid-related diseases. FEBS J. Li, A. Identification and characterization of CircRNAs of two pig breeds as a new biomarker in metabolism-related diseases. Biochem 47 , — Arcinas, C. Adipose circular RNAs exhibit dynamic regulation in obesity and functional role in adipogenesis. Lin, X. Front Cell Dev. Li, Q. CircACC1 Regulates Assembly and Activation of AMPK Complex under Metabolic Stress. e7 Du, R. Med 20 , Nayfach, S. New insights from uncultivated genomes of the global human gut microbiome. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature , Derrien, M. The gut microbiota in the first decade of life. Trends Microbiol 27 , — Rinninella, E. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7 , 14 David, L. Diet rapidly and reproducibly alters the human gut microbiome. Shi, Z. Gut microbiota: An important link between western diet and chronic diseases. Nutrients 11 , Quiroga, R. Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children. Clauss, M. Interplay between exercise and gut microbiome in the context of human health and performance. Front Nutr. Matenchuk, B. Sleep, circadian rhythm, and gut microbiota. Ramirez, J. Antibiotics as major disruptors of gut microbiota. Front Cell Infect. Microbiol 10 , Awany, D. Host and microbiome genome-wide association studies: current state and challenges. Front Genet 9 , Cahana, I. Impact of host genetics on gut microbiome: Take-home lessons from human and mouse studies. Model Exp. Gut microbiome and its role in obesity and insulin resistance. Gérard, C. Impact of gut microbiota on host glycemic control. Del Chierico, F. Fecal microbiota signatures of insulin resistance, inflammation, and metabolic syndrome in youth with obesity: a pilot study. Acta Diabetol. Wu, H. The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study. Andoh, A. Biochem Nutr. Agus, A. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 70 , — Martin, A. The influence of the gut microbiome on host metabolism through the regulation of gut hormone release. Scheithauer, T. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol. de Groot, P. Genetics: Family history and certain genetic factors can predispose individuals to insulin resistance. Specific gene variants are associated with impaired insulin signalling and glucose metabolism. However, it's important to remember that genetics alone do not determine the development of insulin resistance - environment and lifestyle factors almost always play a role. Processed diet: A diet high in refined carbohydrates, sugary foods, and saturated fats can contribute to insulin resistance. Consuming excessive amounts of these foods can lead to chronically elevated blood sugar levels and subsequent insulin overproduction, leading to insulin resistance over time. Chronic inflammation: Inflammation, often associated with conditions like obesity and metabolic syndrome, can interfere with insulin signalling pathways and promote insulin resistance. Over time, insulin resistance can lead to the development of type 2 diabetes, as the pancreas compensates by producing more insulin to overcome the reduced effectiveness of insulin. As such, prolonged insulin resistance can overwhelm the pancreas and cause it to fail, leading to insulin deficiency and high blood sugar levels. Insulin plays a crucial role in muscle development by regulating various metabolic processes. When insulin is released by the pancreas in response to increased blood sugar levels, it facilitates the uptake of glucose into muscle cells. This glucose serves as an energy source for muscle contraction and replenishes glycogen stores for future use. Furthermore, insulin promotes protein synthesis in muscle tissue. It stimulates the transportation of amino acids into muscle cells, which are the building blocks for protein synthesis. Increased insulin levels also inhibit protein breakdown, creating a more favourable environment for muscle growth and repair. Insulin also aids in nutrient delivery to muscles by enhancing blood flow. It promotes vasodilation, leading to increased blood circulation and nutrient supply to muscle tissue. This ensures a sufficient oxygen and nutrient supply for optimal muscle function and growth. However, it's important to note that while insulin supports muscle development, excessive insulin levels resulting from conditions like insulin resistance or diabetes can have negative effects. High insulin levels can contribute to fat storage and actually hinder muscle growth. Therefore, maintaining a balanced insulin response through a healthy diet, regular exercise, and proper insulin management is crucial for maximizing muscle development. It's important to note that finding optimal insulin balance is a complex task influenced by various factors. Maintaining a healthy weight, engaging in regular physical activity, following a balanced diet, and managing other metabolic risk factors are always key. However, there are a few strategies almost anyone can try to optimize muscle mass growth. To improve insulin levels for muscle mass growth, here are some strategies that can be beneficial:. Balanced Diet: This one seems obvious, but still needs to be said. Several studies have examined the effects of both maternal diabetes and maternal metformin exposure on offspring, but prospective fathers have received comparatively little attention. A recent study sought to change that. Diabetes was only the 8th-leading cause of death in Sign-up free to receive the 5 Tactics in my Longevity Toolkit delivered by email as a 5-day course. Non-lame, weekly emails on the latest strategies and tactics for increasing your lifespan, healthspan, and well-being plus new podcast announcements. This field is for validation purposes and should be left unchanged. Comments are welcomed and encouraged. The purpose of comments on our site is to expand knowledge, engage in thoughtful discussion, and learn more from readers. Criticism and skepticism can be far more useful than praise and unflinching belief. Thank you for adding to the discussion. |
Welche nötige Wörter... Toll, die glänzende Idee
wirksam?